ArticleArthritis research & therapy2023

Iguratimod suppresses Tfh cell differentiation in primary Sjögren's syndrome patients through inhibiting Akt/mTOR/STAT3 signaling.

Taibiao Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.